[Federal Register Volume 68, Number 81 (Monday, April 28, 2003)]
[Notices]
[Page 22416]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-10397]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 25, 2002, and published in the Federal 
Register on November 7, 2002, (67 FR 67870), Abbott Laboratories, DBA 
Knoll Pharmaceutical Company, 30 North Jefferson Road, Whippany, New 
Jersey 07981, made application by renewal to the Drug Enforcement 
Administration to be registered as a bulk manufacturer of the basic 
classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Hydromorphone (9150).......................  II
------------------------------------------------------------------------

    The firm plans to manufacture bulk product and finished dosage 
units for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in title 21, United States Code, section 823(a) and 
determined that the registration of Abbott Laboratories, DBA Knoll 
Pharmaceuticals, to manufacture the listed controlled substances is 
consistent with the public interest at this time. DEA has investigated 
Abbott Laboratories, DBA Knoll Pharmaceuticals, to ensure that the 
company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: April 7, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-10397 Filed 4-25-03; 8:45 am]
BILLING CODE 4410-09-M